Dexamethasone significantly attenuates subarachnoid hemorrhage-induced elevation in cerebrospinal fluid citrulline and leukocytes

Journal of Neurosurgical Sciences

Volumn 56, Issue 4, 2012, Pages 363-371

  Spratt, D E ^a   Reddy, V K ^b   Choxi, A A ^b   Simon, S D ^c   Shay, S D ^b   Davidson, M A ^b   Barr, F E ^d   Summar, M L ^e   Mericle, R A ^f  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f HW Neurological Institute   (United States)

Author keywords

Citrulline; Dexamethasone; Rabbits; Subarachnoid hemorrhage; Vasospasm, intracranial

Indexed keywords

BIOLOGICAL MARKER; CITRULLINE; DEXAMETHASONE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; EXPERIMENTAL RABBIT; LEUKOCYTE; LEUKOCYTOSIS; NONHUMAN; SUBARACHNOID HEMORRHAGE; VASOSPASM;

ANIMALS; CITRULLINE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; LEUKOCYTES; NITRIC OXIDE; RABBITS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84871737276     PISSN: 03905616     EISSN: 18271855     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562-72. (Pubitemid 15007226)
2. Wu CT, Wong CS, Yeh CC, Borel CO. Treatment of cerebral vasospasm after subarachnoid hemorrhage - a review. Acta Anaesthesiol Taiwan 2004;42:215-22. (Pubitemid 40074213)
3. Handa Y, Kabuto M, Kobayashi H, Kawano H, Takeuchi H, Hayashi M. The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery 1991;28:542-9.
4. Alabadi JA, Torregrosa G, Miranda FJ, Salom JB, Centeno JM, Alborch E. Impairment of the modulatory role of nitric oxide on the endothelin-1-elicited contraction of cerebral arteries: a pathogenetic factor in cerebral vasospasm after subarachnoid hemorrhage? Neurosurgery 1997;41:245-52; discussion 252-43.
5. Jung CS, Iuliano BA, Harvey-White J, Espey MG, Oldfield EH, Pluta RM. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 2004;101:836-42. (Pubitemid 39430979)
6. Kasuya H, Weir BK, Nakane M, Pollock JS, Johns L, Marton LS et al. Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg 1995;82:250-5.
7. McGirt MJ, Woodworth GF, Pradilla G, Legnani F, Warner D, Tamargo R et al. Galbraith Award: simvastatin attenuates experimental cerebral vasospasm and ameliorates serum markers of neuronal and endothelial injury in patients after subarachnoid hemorrhage: a dose-response effect dependent on endothelial nitric oxide synthase. Clin Neurosurg 2005;52:371-8.
8. Woszczyk A, Deinsberger W, Boker DK. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage. Acta Neurochir (Wien) 2003;145:257-263; discussion 263-254.
9. Mathiesen T, Andersson B, Loftenius A, von Holst H. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 1993;78:562-7. (Pubitemid 23099464)
10. Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M et al. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) 1998;140:943-51. (Pubitemid 28474664)
11. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992;263(1 Pt 1):C1-16.
12. Lee TJ. Nitric oxide and the cerebral vascular function. J Biomed Sci 2000;7:16-26. (Pubitemid 30046567)
13. Vatter H, Weidauer S, Dias S, Preibisch C, Ngone S, Raabe A et al. Persistence of the nitric oxide-dependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage. Neurosurgery 2007;60:179-87; discussion 187-178.
14. Ananthakrishnan M, Barr FE, Summar ML, Smith HA, Kaplowitz M, Cunningham G et al. L-Citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 2009;297:L506-11.
15. Barr FE, Tirona RG, Taylor MB, Rice G, Arnold J, Cunningham G et al. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension. J Thorac Cardiovasc Surg 2007;134:319-26. (Pubitemid 47088581)
16. Pearson DL, Dawling S, Walsh WF, Haines JL, Christman BW, Bazyk A et al. Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 2001;344:1832-8. (Pubitemid 32538696)
17. Smith HA, Canter JA, Christian KG, Drinkwater DC, Scholl FG, Christman BW et al. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg 2006;132:58-65.
18. Radomski MW, Palmer RM, Moneada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990;87:10043-7. (Pubitemid 120016581)
19. Suzuki H. New insight from the interplay between nitric oxide and glucocorticoids. Crit Care Med 2004;32:2362-3. (Pubitemid 39491832)
20. Girard P, Pansart Y, Gillardin JM. Inducible nitric oxide synthase involvement in the mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhoea in rats. Nitric Oxide 2005;13:163-9. (Pubitemid 41443560)
21. Chaichana KL, Pradilla G, Huang J, Tamargo RJ. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg 2010;73:22-41.
22. Spreer A, Gerber J, Hanssen M, Schindler S, Hermann C, Lange P et al. Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis. Pediatr Res 2006;60:210-5. (Pubitemid 44297595)
23. Trenque T, Lamiable D, Vistelle R, Millart H, Leperre A, Choisy H. Comparative pharmacokinetics of two diastereoisomers dexamethasone and betamethasone in plasma and cerebrospinal fluid in rabbits. Fundam Clin Pharmacol 1994;8:430-6. (Pubitemid 24332327)
24. Chen J. Animal models of acute neurological injuries. Totowa, NJ: Humana Press; 2009.
25. Chan RC, Durity FA, Thompson GB, Nugent RA, Kendall M. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. J Neurosurg 1984;61:1120-8. (Pubitemid 15182259)
26. Salvetti DJ, Sinha TK, Wilson KJ, Shay SD, Spratt DE, Mericle RA. An automated algorithm to improve the precision of basilar artery diameter measurements before and after subarachnoid hemorrhage-induced vasospasm in an animal model. Neurosurgery. 2010;66:137-142; discussion 142-143.
27. Hall ED, Travis MA. Attenuation of progressive brain hypoperfusion following experimental subarachnoid hemorrhage by large intravenous doses of methylprednisolone. Exp Neurol 1988;99:594-606. (Pubitemid 18080765)
28. Yamakawa K, Sasaki T, Tsubaki S, Nakagomi T, Saito I, Takakura K. Effect of high-dose methylprednisolone on vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1991;31:24-31.
29. Gomis P, Tran-Dinh YR, Sercombe C, Sercombe R. Dexamethasone preventing contractile and cytoskeletal protein changes in the rabbit basilar artery after subarachnoid hemorrhage. J Neurosurg 2005;102:715-20. (Pubitemid 43186677)
30. Chyatte D, Fode NC, Nichols DA, Sundt TM Jr. Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987;21:157-60. (Pubitemid 17131115)
31. Fei L, Golwa F. Topical application of dexamethasone to prevent cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a pilot study. Clin Drug Investig 2007;27:827-32. (Pubitemid 350145436)
32. Hashi K, Takakura K, Sano K, Ohta T, Saito I, Okada K. [Intravenous hydrocortisone in large doses in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage - results of a multi-center controlled double-blind clinical study]. No To Shinkei 1988;40:373-82.
33. Ohkuma H, Suzuki S, Ogane K, Fujita S, Shibata S, Ito K et al. [Preventive effect of intracisternal methylprednisolone on symptomatic vasospasm after aneurysmal subarachnoid hemorrhage]. No Shinkei Geka 1996;24:135-42.
34. Suzuki S, Ogane K, Souma M, Ohkuma H, Iwabuchi T. Efficacy of steroid hormone in solution for intracranial irrigation during aneurysmal surgery for prevention of the vasospasm syndrome. Acta Neurochir (Wien) 1994;131:184-8.
35. Yasukawa K, Kamijou Y, Momose G, Kobayashi S, Kuroyanagi T, Morota N et al. [The experiences of a large amount of steroid therapy for symptomatic vasospasm after subarachnoid hemorrhage: clinical analysis of 21 cases], No Shinkei Geka 1994;22:17-22.
36. Gomis P, Graftieaux JP, Sercombe R, Hettler D, Scherpereel B, Rousseaux P. Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J Neurosurg 2010;112:681-8.
37. Schurkamper M, Medele R, Zausinger S, Schmid-Elsaesser R, Steiger HJ. Dexamethasone in the treatment of subarachnoid hemorrhage revisited: a comparative analysis of the effect of the total dose on complications and outcome. J Clin Neurosci 2004;11:20-4. (Pubitemid 37516783)
38. Feigin VL, Anderson N, Rinkel GJ, Algra A, van Gijn J, Bennett DA. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev 2005;3:CD004583.
39. Sobey CG, Faraci FM. Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 1998;25:867-76. (Pubitemid 28500825)
40. Fassbender K, Ries S, Schminke U, Schneider S, Hennerici M. Inflammatory cytokines in CSF in bacterial meningitis: association with altered blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 1996;61:57-61. (Pubitemid 26232029)
41. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K. Raised plasma endothelin in aneurysmal subar
42. Suzuki H, Sato S, Suzuki Y, Oka M, Tsuchiya T, Iino I et al. Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage. Ann Med 1990;22:233-6. (Pubitemid 20361859)
43. Schultz BR, Allen CH, Kaplan SL. Corticosteroids for acute bacterial meningitis. Ann Emerg Med 2009;54:136-7; author reply 137-8.
44. Chyatte D. Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke 1989;20:1021-6. (Pubitemid 19204014)
45. Lombardi D, Gaetani P, Marzatico F, Cafe C, Rodriguez y Baena R. Effect of high-dose methylprednisolone on antioxidant enzymes after experimental SAH. J Neurol Sci 1992;111:13-9.